RXST RxSight, Inc.
Nasdaq · SEC CIK 1111485 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $118.0K 4 sales by 4 insiders
- Filings on record
- 186 since 2021-08-02, latest 2026-09-16 16:25
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wilterding Mark | CFO | — | $54.0K |
| Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| Goldshleger Ilya | See remarks | — | $14.2K |
| Weinberg Eric | See remarks | — | $14.2K |
| Gaines Scott | Chief Customer Off | — | — |
| Fountain Tamara | Dir | — | — |
| Corley Jesse Anderson | Dir | — | — |
| Warner Robert Keith | Dir | — | — |
| Maniar Shweta | Dir | — | — |
| Andrews Julie | Dir | — | — |
Transactions 218
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-05 | 2021-08-05 | RXST | Kurtz Ronald M MD | See Remarks, Dir | P - Purchase | $13.85 | +3,638 | 804.6K | +0.5% | +$50.4K |
| D | 2021-08-05 | 2021-08-03 | RXST | Schwartz Daniel Mark | Dir | C - Cnv Deriv | $0.00 | +3,969 | 407.6K | +1.0% | $0 |
| M | 2021-08-05 | 2021-08-03 | RXST | PALMISANO ROBERT J | Dir | A - Grant | $0.00 | +13.4K | 13.4K | New | $0 |
| D | 2021-08-05 | 2021-08-03 | RXST | LINK WILLIAM J PHD | Dir, 10% | P - Purchase | $16.00 | +31.2K | 37.1K | +533% | +$500.0K |
| DI | 2021-08-05 | 2021-08-03 | RXST | LINK WILLIAM J PHD | Dir, 10% | C - Cnv Deriv | $0.00 | +2.02M | 2.02M | New | $0 |
| DI | 2021-08-05 | 2021-08-03 | RXST | Robertson Bruce C | Dir | C - Cnv Deriv | $0.00 | +1.39M | 1.39M | New | $0 |
| 2021-08-05 | 2021-08-03 | RXST | Weinberg Eric | Chief Commercial Off | P - Purchase | $16.00 | +31.2K | 31.2K | New | +$500.0K | |
| DMI | 2021-08-05 | 2021-08-03 | RXST | Tammenoms Bakker Juliet | Dir | P - Purchase | $16.00 | +625.0K | 500.0K | New | +$10.00M |
| DI | 2021-08-05 | 2021-08-03 | RXST | Tammenoms Bakker Juliet | Dir | C - Cnv Deriv | $0.00 | +1.86M | 1.86M | New | $0 |
| D | 2021-08-05 | 2021-08-03 | RXST | Tammenoms Bakker Juliet | Dir | P - Purchase | $16.00 | +12.5K | 18.4K | +213% | +$200.0K |
| D | 2021-08-05 | 2021-08-03 | RXST | RxSight I, LLC | 10% | C - Cnv Deriv | $0.00 | +2.02M | 2.02M | New | $0 |
| 2021-08-05 | 2021-08-03 | RXST | Andrews Julie | Dir | P - Purchase | $16.00 | +15.6K | 29.0K | +117% | +$250.0K | |
| M | 2021-08-05 | 2021-08-03 | RXST | Andrews Julie | Dir | A - Grant | $0.00 | +13.4K | 5,733 | New | $0 |
| DI | 2021-08-05 | 2021-08-03 | RXST | Wolfen Richard M. | Dir | C - Cnv Deriv | $0.00 | +1.49M | 1.76M | +547% | $0 |
| D | 2021-08-05 | 2021-08-03 | RXST | Wolfen Richard M. | Dir | C - Cnv Deriv | $0.00 | +77.0K | 78.2K | +6,436% | $0 |
| 2021-08-02 | 2021-07-30 | RXST | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +5,859 | 5,859 | New | $0 | |
| 2021-08-02 | 2021-07-30 | RXST | Corley Jesse Anderson | Dir | A - Grant | $0.00 | +5,859 | 5,859 | New | $0 | |
| 2021-08-02 | 2021-07-30 | RXST | LINK WILLIAM J PHD | Dir | A - Grant | $0.00 | +5,859 | 5,859 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations